Adagene (ADAG) Competitors

Amarin (NASDAQ:AMRN) and Adagene (NASDAQ:ADAG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

Do institutionals and insiders hold more shares of AMRN or ADAG?

22.3% of Amarin shares are owned by institutional investors. Comparatively, 9.5% of Adagene shares are owned by institutional investors. 3.3% of Amarin shares are owned by insiders. Comparatively, 21.2% of Adagene shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has more volatility and risk, AMRN or ADAG?

Amarin has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, Adagene has a beta of 0.74, suggesting that its stock price is 26% less volatile than the S&P 500.

Is AMRN or ADAG more profitable?

Adagene has a net margin of 0.00% compared to Amarin's net margin of -41.07%. Adagene's return on equity of 0.00% beat Amarin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amarin	-41.07%	-17.21%	-12.16%
Adagene	N/A	N/A	N/A

Does the media prefer AMRN or ADAG?

In the previous week, Adagene had 2 more articles in the media than Amarin. MarketBeat recorded 4 mentions for Adagene and 2 mentions for Amarin. Amarin's average media sentiment score of 1.09 beat Adagene's score of 0.24 indicating that Amarin is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amarin	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Adagene	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do analysts recommend AMRN or ADAG?

Amarin presently has a consensus price target of $12.00, suggesting a potential downside of 24.29%. Adagene has a consensus price target of $8.00, suggesting a potential upside of 306.09%. Given Adagene's stronger consensus rating and higher possible upside, analysts plainly believe Adagene is more favorable than Amarin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amarin	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Adagene	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has better earnings & valuation, AMRN or ADAG?

Adagene has lower revenue, but higher earnings than Amarin.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amarin	$214.11M	1.53	-$82.18M	-$3.64	-4.35
Adagene	$100K	928.07	-$33.42M	N/A	N/A

Summary

Adagene beats Amarin on 10 of the 14 factors compared between the two stocks.